Trenton, NJ – According to New Jersey Business Magazine, “Actions taken by the Board of the New Jersey Economic Development Authority (EDA) today under the Grow New Jersey Assistance Program (Grow NJ) include projects that support the attraction of businesses in the manufacturing industry that hold the promise of creating over 450 new jobs and leveraging the private investment of more than $26.2 million in New Jersey’s economy. Advanced under the New Jersey Economic Opportunity Act of 2013, Grow NJ is the state’s main job creation incentive program.”
0 Comments
Washington D.C. - The U.S. Small Business Administration (SBA) released a combined synopsis/solicitation with the intention of awarding up to three contracts for entities to head regional innovation cluster initiatives. SBA intends to make three awards including one to an entity that will provide cluster initiative services to a community affected by changes in the coal economy.
Washington D.C. - According to SSTI, "It has long been known that academic institutions are a key driver of research and development performance in the United States. While industry still funds and performs the majority of R&D in the U.S., universities and colleges (U&C) play a pivotal role in the advancement of basic human knowledge.
New Brunswick, NJ - Janssen Pharmaceutical has furthered its strategic partnership with the Rutgers University School of Engineering by providing $6 million to expand research that will help pharmaceutical companies develop new ways to manufacture prescription medicines.
Ewing, NJ - Until recently, all Mehak Aswani, Pauleena Pal, and Sheenal Parikh had to show for their future restaurant, Tikka Roll, was an Excel file full of projected sales figures and long list of needs, including a fridge, a sink, and a fryer. But after winning first prize in the 2015 Mayo Business Plan Competition on April 8, the three seniors have $22,000 to put toward making the restaurant a reality.
Trenton, NJ - An altered and diminished labor market has driven many people – from recent college graduates to retirees – to form their own high-tech startup companies, and their efforts have been facilitated by a robust Internet era, which features easy access to relevant information, as well as smooth communications with colleagues and other experts.
Chatham, NJ - According to Kim Case of the R&D Council, "Home to 14 of the top 20 biopharmaceutical companies and the world’s highest concentration of scientific professionals and world-class research institutions, New Jersey continues to position itself as a hub for Science, Technology, Engineering and Math (STEM) discovery. Supporting the state’s position is the Research & Development Council of New Jersey, which brings industry, academia and government together with one voice to ensure New Jersey continues to have a thriving environment for innovation."
Trenton, NJ - According to Melissa Orsen of the NJEDA, "The New Jersey Economic Development Authority (EDA) is an independent state agency that finances small and mid-sized businesses, administers tax incentives to retain and grow jobs, revitalizes communities through redevelopment initiatives, and supports entrepreneurial development by providing access to training and mentoring programs."
Philadelphia, PA - James C. Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), is thrilled that the 2015 BIO International Convention is being held in Philadelphia. When he first joined the organization 10 years ago, the annual convention was on his home turf. Held at various US locations since that time, industry representatives from New Jersey, Delaware and Pennsylvania had been asking him: “When is BIO International coming back to the area?”
Trenton, NJ - Since arriving at the Commercialization Center for Innovative Technologies (CCIT) in North Brunswick just over a year ago, Aucta Pharmaceuticals has built a name for itself within New Jersey’s life sciences community. The company has already secured multiple sources of funding and its co-founder and Chief Executive Officer Dr. Shoufeng Li is highly regarded within the industry. The new drug product development company concentrates on novel and niche generic product development. In addition, Aucta Pharmaceutical offers proprietary technology focusing on poor water soluble compounds, controlled release dosage forms and compliance enhancing formulations.
Washington D.C. - The second in SSTI’s series on basic research, this article focuses on the ways that the funding sources of R&D and basic research have changed over time. Ultimately, the nature of basic research – long horizons, unknown rewards, and high costs – indicates why some sectors, namely the private sector, may seek shorter term options. A better understanding of the changing nature of funding sources for basic research may be useful in understanding the current state of research and development in the U.S.
Washington D.C. - "Technology has potential to radically improve our lives." That is the last line in Congressman LoBiondo's recent OpEd in the Courier Post. He discussed the importance in investing aerospace technologies and the United States as well as New Jersey are ready to lead in their industry. Below is his original article.
Trenton, NJ - According to Andrew George of NJBiz, "The American Dream Meadowlands project has grown significantly enough since it received approval from the Economic Development Authority in November 2013 for a $390 million Economic Redevelopment and Growth grant — the largest ever of its kind — that the board will need to revisit the application and approve of its modifications in the coming months."
Woodcliff, NJ - Endo International plc and Woodcliff Lakes-based Par Pharmaceutical Holdings, Inc. today announced that they have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. The combination will create a leading specialty pharmaceutical company with a generics business that is one of the industry’s fastest growing and among the top five as measured by U.S. sales. It is also expected to help drive long-term double-digit revenue growth for Endo.
Washington D.C. - According to SSTI, "Innovation in the United States, once a hallmark of economic success, finds itself resting on an increasingly weak foundation, according to an article in The New York Times. The author, Eduardo Porter, suggests that two trends – increased international competition and a stagnant R&D-to-GDP ratio – pose key challenges for the U.S."
|
Do not miss a single innovative moment and sign up for our newsletter!
|